Precision Optics Corporation, Inc. (POCI)
USD 5.01
(0.2%)
USD 5.01
(0.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.72 Million USD | -326.64% |
| 2023 | -638.54 Thousand USD | 52.76% |
| 2022 | -1.35 Million USD | -49.27% |
| 2021 | -905.58 Thousand USD | 36.36% |
| 2020 | -1.42 Million USD | -193.74% |
| 2019 | -484.43 Thousand USD | -38.96% |
| 2018 | -348.61 Thousand USD | 65.22% |
| 2017 | -1 Million USD | 5.02% |
| 2016 | -1.05 Million USD | 12.99% |
| 2015 | -1.21 Million USD | -4.6% |
| 2014 | -1.15 Million USD | 5.91% |
| 2013 | -1.23 Million USD | 4.06% |
| 2012 | -1.28 Million USD | -29.52% |
| 2011 | -991.9 Thousand USD | -145.44% |
| 2010 | -404.14 Thousand USD | 25.52% |
| 2009 | -542.63 Thousand USD | 66.55% |
| 2008 | -1.62 Million USD | 44.72% |
| 2007 | -2.93 Million USD | -27.17% |
| 2006 | -2.3 Million USD | 38.26% |
| 2005 | -3.73 Million USD | -0.99% |
| 2004 | -3.7 Million USD | -23.98% |
| 2003 | -2.98 Million USD | 70.57% |
| 2002 | -10.14 Million USD | -124.96% |
| 2001 | -4.5 Million USD | -87.07% |
| 2000 | -2.41 Million USD | -41.8% |
| 1999 | -1.7 Million USD | 19.05% |
| 1998 | -2.1 Million USD | -320.0% |
| 1997 | -500 Thousand USD | -225.0% |
| 1996 | 400 Thousand USD | -42.86% |
| 1995 | 700 Thousand USD | 0.0% |
| 1994 | - USD | 100.0% |
| 1993 | -1.4 Million USD | -1300.0% |
| 1992 | -100 Thousand USD | -150.0% |
| 1991 | 200 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -704.16 Thousand USD | -73.74% |
| 2024 Q4 | -1.35 Million USD | -424.64% |
| 2024 Q1 | -405.29 Thousand USD | 34.05% |
| 2024 Q3 | -258.52 Thousand USD | 63.29% |
| 2023 Q4 | -614.54 Thousand USD | -24.59% |
| 2023 Q3 | -493.26 Thousand USD | -170.79% |
| 2023 Q2 | 696.81 Thousand USD | 4300.48% |
| 2023 Q1 | -16.58 Thousand USD | 96.15% |
| 2023 FY | -638.54 Thousand USD | 52.76% |
| 2022 Q4 | -430.51 Thousand USD | -604.37% |
| 2022 FY | -1.35 Million USD | -49.27% |
| 2022 Q1 | -571.95 Thousand USD | -30.45% |
| 2022 Q2 | -460.35 Thousand USD | 19.51% |
| 2022 Q3 | -61.12 Thousand USD | 86.72% |
| 2021 Q2 | -212.72 Thousand USD | -13395.31% |
| 2021 Q4 | -438.44 Thousand USD | -71.25% |
| 2021 FY | -905.58 Thousand USD | 36.36% |
| 2021 Q1 | 1600.00 USD | 100.5% |
| 2021 Q3 | -256.01 Thousand USD | -20.35% |
| 2020 Q3 | -465.44 Thousand USD | 15.62% |
| 2020 Q1 | -85.88 Thousand USD | 20.46% |
| 2020 FY | -1.42 Million USD | -193.74% |
| 2020 Q4 | -320.05 Thousand USD | 31.24% |
| 2020 Q2 | -551.59 Thousand USD | -542.27% |
| 2019 Q1 | -298.78 Thousand USD | -1731.16% |
| 2019 Q2 | -125.6 Thousand USD | 57.96% |
| 2019 Q4 | -107.97 Thousand USD | -34.67% |
| 2019 FY | -484.43 Thousand USD | -38.96% |
| 2019 Q3 | -80.17 Thousand USD | 36.17% |
| 2018 Q4 | 18.31 Thousand USD | 106.57% |
| 2018 FY | -348.61 Thousand USD | 65.22% |
| 2018 Q1 | -28.26 Thousand USD | 87.99% |
| 2018 Q2 | -59.84 Thousand USD | -111.69% |
| 2018 Q3 | -278.82 Thousand USD | -365.92% |
| 2017 Q3 | -162.77 Thousand USD | 47.85% |
| 2017 FY | -1 Million USD | 5.02% |
| 2017 Q1 | -293.4 Thousand USD | -97.51% |
| 2017 Q2 | -312.09 Thousand USD | -6.37% |
| 2017 Q4 | -235.38 Thousand USD | -44.61% |
| 2016 FY | -1.05 Million USD | 12.99% |
| 2016 Q3 | -243.67 Thousand USD | 13.38% |
| 2016 Q2 | -281.31 Thousand USD | 26.34% |
| 2016 Q1 | -381.89 Thousand USD | -6.59% |
| 2016 Q4 | -148.55 Thousand USD | 39.04% |
| 2015 Q3 | -237.1 Thousand USD | 26.19% |
| 2015 FY | -1.21 Million USD | -4.6% |
| 2015 Q2 | -321.22 Thousand USD | -8.36% |
| 2015 Q1 | -296.43 Thousand USD | 6.23% |
| 2015 Q4 | -358.28 Thousand USD | -51.11% |
| 2014 Q1 | -210.72 Thousand USD | -22.37% |
| 2014 Q3 | -380.43 Thousand USD | -50.69% |
| 2014 FY | -1.15 Million USD | 5.91% |
| 2014 Q2 | -252.45 Thousand USD | -19.8% |
| 2014 Q4 | -316.11 Thousand USD | 16.91% |
| 2013 Q1 | -356.84 Thousand USD | -63.47% |
| 2013 Q4 | -172.19 Thousand USD | 50.8% |
| 2013 Q2 | -353.47 Thousand USD | 0.94% |
| 2013 Q3 | -349.99 Thousand USD | 0.98% |
| 2013 FY | -1.23 Million USD | 4.06% |
| 2012 FY | -1.28 Million USD | -29.52% |
| 2012 Q3 | -490.89 Thousand USD | -57.16% |
| 2012 Q2 | -312.34 Thousand USD | -18.67% |
| 2012 Q1 | -263.2 Thousand USD | -7.17% |
| 2012 Q4 | -218.29 Thousand USD | 55.53% |
| 2011 FY | -991.9 Thousand USD | -145.44% |
| 2011 Q1 | -142.97 Thousand USD | -1580.24% |
| 2011 Q2 | -316.02 Thousand USD | -121.03% |
| 2011 Q3 | -287.31 Thousand USD | 9.08% |
| 2011 Q4 | -245.59 Thousand USD | 14.52% |
| 2010 Q4 | 9659.00 USD | 114.42% |
| 2010 Q2 | -239.39 Thousand USD | -122.82% |
| 2010 Q3 | -66.97 Thousand USD | 72.02% |
| 2010 Q1 | -107.43 Thousand USD | -5.65% |
| 2010 FY | -404.14 Thousand USD | 25.52% |
| 2009 Q1 | -244.41 Thousand USD | 24.49% |
| 2009 FY | -542.63 Thousand USD | 66.55% |
| 2009 Q2 | -36.76 Thousand USD | 84.96% |
| 2009 Q3 | -159.75 Thousand USD | -334.51% |
| 2009 Q4 | -101.69 Thousand USD | 36.35% |
| 2008 FY | -1.62 Million USD | 44.72% |
| 2008 Q2 | -696.44 Thousand USD | -47.66% |
| 2008 Q1 | -471.65 Thousand USD | 21.87% |
| 2008 Q4 | -323.7 Thousand USD | -147.87% |
| 2008 Q3 | -130.59 Thousand USD | 81.25% |
| 2007 Q3 | -857.28 Thousand USD | -11.25% |
| 2007 FY | -2.93 Million USD | -27.17% |
| 2007 Q4 | -603.68 Thousand USD | 29.58% |
| 2007 Q2 | -770.57 Thousand USD | -9.55% |
| 2007 Q1 | -703.38 Thousand USD | -15.35% |
| 2006 Q2 | -642.65 Thousand USD | -12.94% |
| 2006 Q1 | -569.01 Thousand USD | 49.37% |
| 2006 FY | -2.3 Million USD | 38.26% |
| 2006 Q4 | -609.78 Thousand USD | -25.36% |
| 2006 Q3 | -486.43 Thousand USD | 24.31% |
| 2005 Q2 | -835.21 Thousand USD | 11.72% |
| 2005 Q4 | -1.12 Million USD | -34.91% |
| 2005 Q3 | -832.98 Thousand USD | 0.27% |
| 2005 Q1 | -946.05 Thousand USD | 6.55% |
| 2005 FY | -3.73 Million USD | -0.99% |
| 2004 Q1 | -643.85 Thousand USD | 37.93% |
| 2004 Q4 | -1.01 Million USD | 0.93% |
| 2004 Q3 | -1.02 Million USD | 0.12% |
| 2004 Q2 | -1.02 Million USD | -58.9% |
| 2004 FY | -3.7 Million USD | -23.98% |
| 2003 Q1 | -801.58 Thousand USD | 40.58% |
| 2003 Q4 | -1.03 Million USD | -139.74% |
| 2003 Q3 | -432.69 Thousand USD | 39.38% |
| 2003 Q2 | -713.79 Thousand USD | 10.95% |
| 2003 FY | -2.98 Million USD | 70.57% |
| 2002 FY | -10.14 Million USD | -124.96% |
| 2002 Q2 | -2.03 Million USD | 66.0% |
| 2002 Q1 | -5.99 Million USD | -611.39% |
| 2002 Q3 | -1.16 Million USD | 42.9% |
| 2002 Q4 | -1.34 Million USD | -15.94% |
| 2001 Q1 | -662.63 Thousand USD | -21.33% |
| 2001 FY | -4.5 Million USD | -87.07% |
| 2001 Q3 | -1.52 Million USD | -40.53% |
| 2001 Q4 | -842.61 Thousand USD | 44.74% |
| 2001 Q2 | -1.08 Million USD | -63.76% |
| 2000 FY | -2.41 Million USD | -41.8% |
| 2000 Q4 | -546.15 Thousand USD | 23.25% |
| 2000 Q3 | -711.62 Thousand USD | -1.66% |
| 2000 Q2 | -700 Thousand USD | -40.0% |
| 2000 Q1 | -500 Thousand USD | 0.0% |
| 1999 FY | -1.7 Million USD | 19.05% |
| 1999 Q1 | -400 Thousand USD | 42.86% |
| 1999 Q2 | -300 Thousand USD | 25.0% |
| 1999 Q3 | -400 Thousand USD | -33.33% |
| 1999 Q4 | -500 Thousand USD | -25.0% |
| 1998 FY | -2.1 Million USD | -320.0% |
| 1998 Q4 | -700 Thousand USD | -40.0% |
| 1998 Q1 | -300 Thousand USD | 40.0% |
| 1998 Q2 | -600 Thousand USD | -100.0% |
| 1998 Q3 | -500 Thousand USD | 16.67% |
| 1997 Q3 | -400 Thousand USD | -500.0% |
| 1997 Q1 | 200 Thousand USD | 0.0% |
| 1997 Q4 | -500 Thousand USD | -25.0% |
| 1997 FY | -500 Thousand USD | -225.0% |
| 1997 Q2 | 100 Thousand USD | -50.0% |
| 1996 FY | 400 Thousand USD | -42.86% |
| 1996 Q2 | 100 Thousand USD | -50.0% |
| 1996 Q1 | 200 Thousand USD | -33.33% |
| 1996 Q4 | - USD | -100.0% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 300 Thousand USD | 200.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 100.0% |
| 1995 FY | 700 Thousand USD | 0.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q1 | -100 Thousand USD | 87.5% |
| 1994 Q2 | - USD | 100.0% |
| 1994 FY | - USD | 100.0% |
| 1994 Q4 | -100 Thousand USD | -200.0% |
| 1993 Q1 | -200 Thousand USD | 95.65% |
| 1993 Q4 | -800 Thousand USD | -700.0% |
| 1993 Q3 | -100 Thousand USD | 50.0% |
| 1993 FY | -1.4 Million USD | -1300.0% |
| 1993 Q2 | -200 Thousand USD | 0.0% |
| 1992 FY | -100 Thousand USD | -150.0% |
| 1992 Q2 | 1.5 Million USD | -6.25% |
| 1992 Q1 | 1.6 Million USD | 151.61% |
| 1992 Q4 | -4.6 Million USD | -428.57% |
| 1992 Q3 | 1.4 Million USD | -6.67% |
| 1991 Q1 | 1.1 Million USD | 0.0% |
| 1991 Q3 | 1.1 Million USD | 0.0% |
| 1991 Q4 | -3.1 Million USD | -381.82% |
| 1991 FY | 200 Thousand USD | 0.0% |
| 1991 Q2 | 1.1 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 95.276% |
| AngioDynamics, Inc. | -97.71 Million USD | 97.212% |
| AtriCure, Inc. | -26.68 Million USD | 89.79% |
| Avinger, Inc. | -16.63 Million USD | 83.623% |
| Azenta, Inc. | -73.12 Million USD | 96.274% |
| BioLife Solutions, Inc. | -70.82 Million USD | 96.153% |
| The Cooper Companies, Inc. | 533.1 Million USD | 100.511% |
| Daxor Corporation | -177.07 Thousand USD | -1438.519% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 81.972% |
| Femasys Inc. | -14.5 Million USD | 81.222% |
| GlucoTrack, Inc. | -7.1 Million USD | 61.651% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 243.84% |
| Hologic, Inc. | 882.6 Million USD | 100.309% |
| ICU Medical, Inc. | 22.82 Million USD | 111.936% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.154% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 73.473% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 107.347% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 60.52% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 60.52% |
| Masimo Corporation | 136.5 Million USD | 101.996% |
| Microbot Medical Inc. | -9.85 Million USD | 72.356% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 118.565% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 102.198% |
| Nephros, Inc. | -1.59 Million USD | -71.019% |
| NovoCure Limited | -232.87 Million USD | 98.83% |
| NEXGEL, Inc. | -3.47 Million USD | 21.647% |
| NEXGEL, Inc. | -3.47 Million USD | 21.647% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 97.35% |
| OraSure Technologies, Inc. | 54.07 Million USD | 105.038% |
| Pro-Dex, Inc. | 7.17 Million USD | 137.98% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 93.748% |
| Predictive Oncology Inc. | -13.92 Million USD | 80.431% |
| QuidelOrtho Corporation | 139.1 Million USD | 101.959% |
| Repligen Corporation | 54.57 Million USD | 104.992% |
| Sanara MedTech Inc. | -4.21 Million USD | 35.368% |
| STAAR Surgical Company | 28.09 Million USD | 109.696% |
| Sharps Technology, Inc. | -10.12 Million USD | 73.097% |
| Utah Medical Products, Inc. | 16.77 Million USD | 116.238% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 96.795% |
| Jin Medical International Ltd. | 2.86 Million USD | 195.015% |